December 8, 2017
- Speakers: Steve Auten
- Location: Shanghai
2nd China Pharma IP Summit
Pharmaceutical & Life Sciences Litigation chair Steve Auten will participate in the panel discussion "The US Supreme Court Ruling on Amgen vs. Sandoz Case and What Developers Need To Know?" at the 2nd China Pharma IP Summit on Dec. 8 in Shanghai. The panel will include a detailed discussion of the patent dance and notice of commercial marketing as required for biosimilar applicants.
More information and full agenda located here.
In This Article
You May Also Like
Webinar | Cross-Atlantic Equity Plans: Trends & Best Practices for 2023 Technology Webinar Series: How To Avoid a Digital Transformation Relationship Trainwreck